Breast Cancer Research

official impact factor 5.79

Highly Access Letter

A prophylactic vaccine for breast cancer? Why not?

Vincent K Tuohy

Author Affiliations

Cleveland Clinic, Lerner Research Institute, Department of Immunology, NB30, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

Breast Cancer Research 2010, 12:405 doi:10.1186/bcr2775

Published: 8 December 2010

First paragraph (this article has no abstract)

In a recent issue of Breast Cancer Research, Watson and Gusterson wrote a viewpoint article [1] about our strategy for developing a prophylactic breast cancer vaccine [2]. The authors base much of their view on several misconceptions and misrepresentations that we wish to clarify.